04:27 PM EST, 11/07/2024 (MT Newswires) -- Insulet ( PODD ) late Thursday reported Q3 adjusted net income of $0.90 per diluted share, up from $0.71 a year earlier.

Analysts polled by Capital IQ expected $0.76.

Revenue for the quarter ended Sept. 30 was $543.9 million, compared with $432.7 million a year earlier.

Analysts expected $519.3 million.

For 2024, the medical device company is now projecting revenue growth of 20% to 21%, compared with its prior forecast expecting 16% to 19% growth over its $1.70 billion in 2023 revenue.

Analysts are looking for $2.02 billion in revenue for this year.

Shares were up nearly 2% in after-hours activity.